Literature DB >> 408984

Synergy of vancomycin with penicillins and cephalosporins against pseudomonas, klebsiella, and serratia.

H Donabedian, V T Andriole.   

Abstract

A model of antibiotic synergy based on a molecular mechanism of action which blocked sequential steps in a single metabolic pathway was tested. Twenty-five strains each of Pseudomonas, Klebsiella, and Serratia were tested in vitro against three different two drug combinations of vancomycin, carbenicillin, or cephalothin. Synergy was observed when vancomycin was combined with either carbenicillin or cephalothin against isolates of Pseudomonas or Serratia, whereas the combination of carbenicillin and cephalothin did not result in significant synergy against these isolates. The presence of synergy was not related to the sensitivity or resistance of the isolates to the drugs in the combination. Synergy was also observed with all three antibiotic combinations against Klebsiella isolates which may be related to enzyme inactivation by one of the drugs in the combination. These observations support the hypothetical model of antibiotic synergy based on sequential blocking of one biochemical pathway.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 408984      PMCID: PMC2595395     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  16 in total

1.  SEQUENTIAL BLOCKAGE AS A THEORETICAL BASIS FOR DRUG SYNERGISM.

Authors:  M L BLACK
Journal:  J Med Chem       Date:  1963-03       Impact factor: 7.446

2.  SYNERGISTIC ACTIVITY OF PENICILLINS AGAINST PENICILLINASE-PRODUCING GRAM-NEGATIVE BACILLI.

Authors:  R SUTHERLAND; F R BATCHELOR
Journal:  Nature       Date:  1964-02-29       Impact factor: 49.962

3.  Some laboratory and clinical experiences with a new antibiotic, vancomycin.

Authors:  J E GERACI; F R HEILMAN; D R NICHOLS; G T ROSS; W E WELLMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-10-17

4.  Biosynthesis of the peptidoglycan of bacterial cell walls. XIV. Purification and properties of two D-alanine carboxypeptidases from Escherichia coli.

Authors:  K Izaki; J L Strominger
Journal:  J Biol Chem       Date:  1968-06-10       Impact factor: 5.157

5.  Condition of cell-wall mucopeptide in dividing and non-dividing cells of Micrococcus lysodeikticus dis-IIp + .

Authors:  R D King; E A Grula
Journal:  Can J Microbiol       Date:  1972-04       Impact factor: 2.419

6.  Antibiotic sensitivities of nonpigmented serratia marcescens to gentamicin and carbenicillin.

Authors:  G F Thornton; V T Andriole
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

7.  Microdilution antibiotic susceptibility test: examination of certain variables.

Authors:  R C Tilton; L Lieberman; E H Gerlach
Journal:  Appl Microbiol       Date:  1973-11

8.  The demonstration and significance of synergism between -lactam antibiotics.

Authors:  J M Hamilton-Miller
Journal:  J Med Microbiol       Date:  1971-05       Impact factor: 2.472

9.  Antibacterial synergism: a proposal for chemotherapeutic potentiation between trimethoprim and sulfamethoxazole.

Authors:  M Poe
Journal:  Science       Date:  1976-10-29       Impact factor: 47.728

10.  Reversal by a specific peptide (diacetyl-alpha gamma-L-diaminobutyryl-D-alanyl-D-alanine) of vancomycin inhibition in intact bacteria and cell-free preparations.

Authors:  M Nieto; H R Perkins; P E Reynolds
Journal:  Biochem J       Date:  1972-01       Impact factor: 3.857

View more
  5 in total

1.  Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Authors:  Jeffrey Fernandez; Darren Abbanat; Wenchi Shang; Wenping He; Karen Amsler; James Hastings; Anne Marie Queenan; John L Melton; Alfred M Barron; Robert K Flamm; A Simon Lynch
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

2.  Synergism between penicillin G and the antimicrobial ether lipid, rac-1-dodecylglycerol, acting below its critical micelle concentration.

Authors:  H S Ved; E Gustow; R A Pieringer
Journal:  Lipids       Date:  1990-02       Impact factor: 1.880

3.  High-throughput identification and rational design of synergistic small-molecule pairs for combating and bypassing antibiotic resistance.

Authors:  Morgan A Wambaugh; Viplendra P S Shakya; Adam J Lewis; Matthew A Mulvey; Jessica C S Brown
Journal:  PLoS Biol       Date:  2017-06-20       Impact factor: 8.029

4.  Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa.

Authors:  San Tin; Kishore R Sakharkar; Chu Sing Lim; Meena K Sakharkar
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580

5.  Increasing the permeability of Escherichia coli using MAC13243.

Authors:  Claudio Muheim; Hansjörg Götzke; Anna U Eriksson; Stina Lindberg; Ida Lauritsen; Morten H H Nørholm; Daniel O Daley
Journal:  Sci Rep       Date:  2017-12-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.